Departments of Pharmacology and Biochemistry, UT Southwestern Medical Center, 6001 Forest Park Road, Dallas, TX 75390-9041, USA, Department of Chemistry and Institute for Life Sciences, University of Southampton, Highfield, Southampton, SO17 1BJ, UK and Alnylam Pharmaceuticals, 300 Third St., Cambridge, MA 02142, USA.
Nucleic Acids Res. 2013 Oct;41(18):8788-801. doi: 10.1093/nar/gkt594. Epub 2013 Jul 24.
Abasic substitutions within DNA or RNA are tools for evaluating the impact of absent nucleobases. Because of the importance of abasic sites in genetic damage, most research has involved DNA. Little information is available on the impact of abasic substitutions within RNA or on RNA interference (RNAi). Here, we examine the effect of abasic substitutions on RNAi and allele-selective gene silencing. Huntington's disease (HD) and Machado Joseph Disease (MJD) are severe neurological disorders that currently have no cure. HD and MJD are caused by an expansion of CAG repeats within one mRNA allele encoding huntingtin (HTT) and ataxin-3 (ATX-3) proteins. Agents that silence mutant HTT or ATX-3 expression would remove the cause of HD or MJD and provide an option for therapeutic development. We describe flexible syntheses for abasic substitutions and show that abasic RNA duplexes allele-selectively inhibit both mutant HTT and mutant ATX-3. Inhibition involves the RNAi protein argonaute 2, even though the abasic substitution disrupts the catalytic cleavage of RNA target by argonaute 2. Several different abasic duplexes achieve potent and selective inhibition, providing a broad platform for subsequent development. These findings introduce abasic substitutions as a tool for tailoring RNA duplexes for gene silencing.
碱基缺失是评估缺失核碱基影响的工具。由于碱基缺失在遗传损伤中的重要性,大多数研究都涉及 DNA。关于 RNA 中碱基缺失的影响或 RNA 干扰 (RNAi) 的信息很少。在这里,我们研究了碱基缺失对 RNAi 和等位基因选择性基因沉默的影响。亨廷顿病 (HD) 和 Machado-Joseph 病 (MJD) 是两种严重的神经退行性疾病,目前尚无治愈方法。HD 和 MJD 是由编码 huntingtin (HTT) 和 ataxin-3 (ATX-3) 蛋白的一个 mRNA 等位基因中的 CAG 重复扩增引起的。沉默突变 HTT 或 ATX-3 表达的药物将消除 HD 或 MJD 的病因,并为治疗开发提供一种选择。我们描述了碱基缺失的灵活合成方法,并表明碱基缺失 RNA 双链体等位基因选择性地抑制突变 HTT 和突变 ATX-3。抑制涉及 RNAi 蛋白 Argonaute 2,尽管碱基缺失破坏了 Argonaute 2 对 RNA 靶标的催化切割。几种不同的碱基缺失双链体实现了强大而选择性的抑制,为后续的发展提供了广泛的平台。这些发现将碱基缺失引入作为一种用于为基因沉默定制 RNA 双链体的工具。